期刊文献+

杀伤细胞免疫球蛋白样受体基因多态性与原发性高血压关系的病例对照研究 被引量:8

Association between polymorphisms of killer cell immunoglobulin-like receptor gene and the risk of essential hypertension: a case-control study
原文传递
导出
摘要 目的 探讨杀伤细胞免疫球蛋白样受体(KIR)基因多态性与原发性高血压的关联性.方法 以社区资料为基础,采用病例对照研究方法,分析按年龄±2岁、同性别1∶1匹配的205对原发性高血压患者(病例组)和正常对照(对照组).应用PCR-SSP方法检测KIR基因,利用广义多因子降维模型(GMDR)和SAS 9.1软件分析数据.结果 KIR各基因频率在病例组和对照组间的差异无统计学意义(P>0.05).KIR基因型9(不携带KIR3DSl和2DS3)在病例组的携带率高于对照组,差异有统计学意义(P<0.05).GMDR显示,KIR2DS2和KIR2DS3两个基因的交互作用检验精确度最高(55.13%),交叉验证一致性为10/10,P=0.054.多因素分析显示,在调整了BMI、吸烟、饮酒和高血压家族史后,KIR2DS2阳性而KIR2DS3阴性者患原发性高血压的危险增加(OR=2.555,95%CI:1.203- 5.429,P=0.015);KIR2DS2阳性且KIR2DS3阳性者患原发性高血压的危险降低(OR=0.268,95%CI:0.088- 0.815,P=0.020);KIR2DS2阴性且KIR2DS3阳性者与原发性高血压不存在关联关系(OR=1.602,95%CI:0.785- 3.266,P=0.195),与KIR2DS2阴性且KIR2DS3阴性者相比较.调整BMI、吸烟、饮酒和高血压家族史后,KIR2DS2和KIR2DS3的交互作用与原发性高血压显著关联(OR=0.065,95%CI:0.013- 0.317,P=0.001).无论是未调整或经多因素调整后,KIR各基因及基因型与高血压均不存在关联关系(P>0.05).结论 携带KIR2DS2而不携带KIR2DS3者,患原发性高血压的危险增加;同时携带KIR2DS2和KIR2DS3可减少原发性高血压的患病危险,两者的拮抗作用可能是原发性高血压的保护因素。 Objective To assess the association between killer cell immunoglobulin-like receptor (KIR) gene polymorphisms and the risk of hypertension in autoimmune mechanism.Methods We conducted a case-control study including 205 hypertensives and 205 controls matched with sex and age,from a community-based population.KIR genes of all subjects were genotyped by polymerase chain reaction with sequence-specific primers (PCR-SSP).Conditional logistic regression model and generalized multifactor dimensionality reduction (GMDR) method were used to estimate the association among KIR gene polymorphisms and the risk of hypertension.Results The genotypic frequencies of KIRs were not significantly different between the hypertensives and the control groups (P〉0.05).Among all the models of GMDR concerning the association between interactions of KIR genes and essential hypertension,the testing accuracy of the interaction between K/R2DS2 and KIR2DS3 was the highest (55.13%),with cross-validation consistency as 10/10 (P=0.054).Results from the conditional logistic regression showed that individuals with KIR2DS2 +:KIR2DS3-were significantly associated with an increased risk on hypertension (OR=2.555,95%CI:1.203-5.429,P=0.015).However,individuals with KIR2DS2 +:KIR2DS3 + were significantly associated with a reduced risk of hypertension (0R=0.268,95% CI:0.088-0.815,P=0.020).Individuals with KIR2DS2-KIR2DS3 + did not seem to be associated with the risk of hypertension (0R=1.602,95% C I:0.785-3.266,P=0.195),when compared to the KIR2DS2-KIR2DS3-group.Interactions between KIR2DS2 and KIR2DS3 were significantly associated with the risk of hypertension,after adjusted for BMI,smoking,drinking and family history of hypertension (OR=0.065,95%CI:0.013-0.317,P=0.001).Conclusion Individuals with KIR2DS2 and no KIR2DS3 were associated with the increased risk of hypertension.KIR2DS2 that coexisted with KIR2DS3 were associated with the reduced risk of hypertension.Antagonism between KIR2DS2 and KIR2DS3 might serve as a protect factor for hypertension.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2015年第6期589-593,共5页 Chinese Journal of Epidemiology
基金 国家自然科学基金青年基金(81202270) 国家自然科学基金(81172761,30972531) 江苏省自然科学基金(BK2012542)
关键词 原发性高血压 杀伤细胞免疫球蛋白样受体 基因多态性 病例对照研究 Essential hypertension Killer cell immtmoglobulin-like receptor Gene polymorphism Case-control study
  • 相关文献

参考文献27

  • 1卫生部疾病控制司,原发性高血压联盟(中国),国家心血管病中心.中国原发性高血压防治指南(2010版)[R].2010:2-3.
  • 2Nicolson DJ, Dickinson HO, Campbell F, et al. Lifestyle interventions or drugs for patients with essential hypertension: a systematic review[J],J Hypertens, 2004, 22( 11): 2043-2048.
  • 3De Gusmao Correia ML. Adiposity and hypertension: the inflammatory link[J],J Hypertens,2010,28(7): 1377-1379.
  • 4Gupta V, Sachdeva S, Khan AS, et al. Endothelial dysfunction and inflammation in different stages of essential hypertension[J]. SaudiJ Kidney Dis Transpl,2011 ,22( I) :97-103.
  • 5Pietri P, Vyssoulis G, Vlachopoulos C, et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension[J].J Hypertens , 2006, 24 OJ) : 2231- 2238.
  • 6Bautista LE , Vera LM, Arenas lA, et al. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alphal and essential hypertension[J].J Hum Hypertens,2005, 19(2): 149-154.
  • 7Cottone S, Mule G, Nardi E, et al. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension[J], AmJ Hypertens, 2006,19(3) : 313-318.
  • 8Sung KC, SuhJY, Kim BS, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension[Jl AmJ Hypertens,2003, 16(6) :429-433.
  • 9王艾丽,王凌飞,吉日木图,汪桂艳,佟伟军,张永红.蒙古族人群C-反应蛋白与原发性高血压关系[J].中国公共卫生,2010,26(4):413-415. 被引量:2
  • 10Rodriguez-Iturbe B, Vaziri ND, Herrera-AcostaJ, et al. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all[J]. AmJ Physiol Renal Physiol , 2004,286 ( 4 ) : 606-616.

二级参考文献11

  • 1Keamey PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data[J]. Lancet, 2005,365 : 217 - 223.
  • 2Ueshima H, Zhang X, Choudhury SR. Epidemiology of hypertension in China and Japan[J]. J Hum Hypertens,2(X30,14:765-769.
  • 3Szmitko PE,Wang CH,Weisel RD,et al. New markers of inflammarion and endothelial cell activation, Part I [ J ]. Circulation, 2003,108 : 1917 - 1923.
  • 4Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [ J ]. N Engl J Med, 2000,342: 836 - 843.
  • 5Ridker PM, Rifai N, Stampfer M J, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healtly men [ J]. Circulation ,2000,101 : 1767 - 1772.
  • 6Ridker PM. C-reactive protein and the prediction of ardiovascular events among those at intermediate risk [ J ]. J Am Coll Cardiol, 2007,49 (21) :2129 -2138.
  • 7Bautista LE, Lopex-Jaramillo P, Vera LM, et al. Is C-reactive protein an independent risk factor for essential hypertension? [ J]. J Hypertens,2001,19 (5) :857 - 861.
  • 8Schillaci G,Pirro M,Gemelli F,et al. Increactive protein concentration in never-treated hypertension: the role of systolic and pulse pressures[J]. J Hypertens ,2003 ,21:1841 - 1846.
  • 9张明芝,布仁巴图,李红美,林哲,李永山,张显玉,佟伟军,张永红.蒙古族原发性高血压前期与原发性高血压危险因素聚集[J].中华高血压杂志,2009,17(3):260-263. 被引量:13
  • 10李新立,蒋素华,倪春辉,张海峰,王震震,黄峻,童明庆,马菜云.降压治疗对血清C-反应蛋白和动脉顺应性影响的研究[J].心脑血管病防治,2003,3(4):16-18. 被引量:2

共引文献1

同被引文献83

引证文献8

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部